المصدر: Safety Profile of Tiotropium + Olodaterol Used as Maintenance Treatment in COPD Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05393245Test

Other URLs: https://www.mystudywindow.comTest

المؤلفون: Regeneron Pharmaceuticals

المصدر: A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04456673Test

Other URLs: http://www.copdclinicalstudies.com/?utm_source=ctgovTest

المصدر: A Comparison of the Clinical Effectiveness of Inhaled Triple Therapy (Fluticasone Furoate / Umeclidinium Bromide / Vilanterol) in a Single Inhaler (TRELEGY™ ELLIPTA™) With Inhaled Non-ELLIPTA™ Multiple Inhaler Triple Therapies in COPD Patients in the US Within a Usual Care Setting in a Prospective Pre-Post Study

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03949842Test

المؤلفون: Regeneron Pharmaceuticals

المصدر: A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03930732Test

المؤلفون: Regeneron Pharmaceuticals

المصدر: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03546907Test

المؤلفون: Carelon Research

المصدر: Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03265145Test

Other URLs: https://www.mystudywindow.comTest

المساهمون: Guoqiang Cao,MD, Vice Chair of Department of Respiratory Medicine

المصدر: Davs L, Angus RM, Calverley PM. Oral cortosteros patnts admted to hospal wh exacerbatns of chron obstructe pulmonary dease: a prospecte randomed controlled trl. Lancet. 1999 Aug 7;354(9177):456-60. do 10.1016/s0140-6736(98)11326-0.
Ldenauer PK, Pekow PS, LahtMC, Lee Y, Benjam EM, Rothberg MB. Assoctn of cortostero dose and route of admtratn wh rk of treatment faure acute exacerbatn of chron obstructe pulmonary dease. JAMA. 2010 Jun 16;303(23):2359-67. do 10.1001/jama.2010.796.
LeuppJD, Schuetz P, Bgser R, Bodmer M, Brl M, Drescher T, Duerrg U, Henzen C, Lebrandt Y, Mar S, Mdger D, Muller B, Scherr A, Schdler C, StoecklR, Vtte S, von Garnr C, Tamm M, Ruthauser J. Short-term vs conventnal glucocorto therapy acute exacerbatns of chron obstructe pulmonary dease: the REDUCE randomed clal trl. JAMA. 2013 Jun 5;309(21):2223-31. do 10.1001/jama.2013.5023.
Personalized Variable Versus Fixed Dose Corticosteroids Therapy in Hospitalized Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02147015Test